Antibiotics & the Cost of Agriculture
Modern agriculture does deserve considerable praise for the good that it does. Food is plentiful, relatively cheap and easy to acquire. Instead of having to struggle with raising crops and livestock or hunting and gathering, I can simply drive to the supermarket and stock up with the food I need to not die. However, as with all things, there is a price.
The modern agricultural complex is now highly centralized and industrialized, which does have its advantages and disadvantages. There are also the harms of specific, chosen practices aimed at maximizing profits. While there are many ways to maximize profits, two common ones are to pay the lowest wages possible (which the agricultural industry does—and not just to the migrant laborers, but to the ranchers and farmers) and to shift the costs to others. I will look, briefly, at one area of cost shifting: the widespread use of antibiotics in meat production.
While most people think of antibiotics as a means of treating diseases, food animals are now routinely given antibiotics when they are healthy. One reason for this is to prevent infections: factory farming techniques, as might be imagined, vastly increase the chances of a disease spreading like wildfire among an animal population. Antibiotics, it is claimed, can help reduce the risk of bacterial infections (antibiotics are useless against viruses, of course). A second reason is that antibiotics increase the growth rate of healthy animals, allowing them to pack on more meat in less time—and time is money. These uses allow the industry to continue factory farming and maintain high productivity—which initially seems laudable. The problem is, however, that this use of antibiotics comes with a high price that is paid for by everyone else.
Eric Schlosser wrote “A Safer Food Future, Now”, which appeared in the May 2016 issue of Consumer Reports. In this article, he notes that this practice has contributed significantly to the rise of antibiotic resistant bacteria. Each year, about two million Americans are infected with resistant strains and about 20,000 die. The healthcare cost is about $20 billion. To be fair, the agricultural industry is not the only contributor to this problem: improper use of antibiotics in humans has also added to this problem. That said, the agricultural use of antibiotics accounts for about 75% of all antibiotic usage in the United States, thus converting the factory farms into for resistant bacteria.
The harmful consequences of this antibiotic use have been known for years and there have, not surprisingly, been attempts to address this through legislation. It should, however, come as little surprise that our elected leaders have failed to take action. One likely explanation is that the lobbying on the part of the relevant corporations has been successful in preventing action. After all these is a strong incentive on the part of industry to keep antibiotics in use: this increases profits by enabling factory farming and the faster growth of animals. That said, it could be contended that the lawmakers are ignorant of the harms, doubt there are harms from antibiotics or honestly believe that the harms arising from their use are outweighed by the benefits to society. That is, the lawmakers have credible reasons other than straight up political bribery (or “lobbying” as it is known in polite company). This is a factual matter, albeit one that is difficult to settle: no professional politician who has been swayed by lobbying will attribute her decision to any but the purist of motivations.
This matter is certainly one of ethical concern and, like most large scale ethical matters that involves competing interests, is one that seems best approached by utilitarian considerations. On the side of using the antibiotics, there is the increased productivity (and profits) of the factory farming system of producing food. This allows more and cheaper food to be provided to the population, which can be regarded as pluses. The main reasons to not use the antibiotics, as noted above, are that they contribute to the creation of antibiotic resistant strains that sicken and kill many people (vastly more Americans than are killed by terrorism). This inflicts considerable costs on the sickened and those who are killed as well as those who care about them. There are also the monetary costs in the health care system (although the increased revenue can be tagged as a plus for health care providers). In addition to these costs, there are also other social and economic costs, such as lost hours of work. As this indicates, the cost (illness, death, etc.) of the use of the antibiotics is shifted: the industry does not pay these costs, they are paid by everyone else.
Using a utilitarian calculation requires weighing the cost to the general population against the profits of the industry and the claimed benefits to the general population. Put roughly, the moral question is whether the improved profits and greater food production outweigh the illness, deaths and costs suffered by the public. The people in the government seem to believe that the answer is “yes.”
If the United States were in a food crisis in which the absence of the increased productivity afforded by antibiotics would cause more suffering and death than their presence, then their use would be morally acceptable. However, this does not seem to be the case—while banning this sort of antibiotic use would decrease productivity (and impact profits), the harm of doing this would seem to be vastly exceeded by the reduction in illness, deaths and health care costs. However, if an objective assessment of the matter showed that the ban on antibiotics would not create more benefits than harms, then it would be reasonable and morally acceptable to continue to use them. This is partially a matter of value (in terms of how the harms and benefits are weighted) and partially an objective matter (in terms of monetary and health costs). I am inclined to agree that the general harm of using the antibiotics exceeds the general benefits, but I could be convinced otherwise by objective data.